Study Detail

TitleCGCI: Non-Hodgkin Lymphoma (NHL) – Follicular Lymphoma (FL)
Study TypeOther
Abstract The Office of Cancer Genomics (OCG) at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic a .. [more]
Center NamedbGaP